S&T Bancorp, Inc. Announces Fourth Quarter and Full Year 2024 Results

S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced fourth quarter and full year 2024 earnings. Net income of $33.1 million, or $0.86 per diluted share, for the fourth quarter of 2024 compared to net income of $32.6 million, or $0.85 per diluted share, for the third quarter of 2024 and […]

Berkshire Hills Reports Strong Fourth Quarter Operating Results

$0.46 GAAP EPS; $0.60 Operating EPS — Operating EPS growth of 3% quarter-over-quarter and 28% year-over-year; FY2024 Operating EPS of $2.22 up 4% year-over-year — Average deposit growth of 3% and Average loan growth of 0.4% quarter-over-quarter; Loans to deposits ratio improved further during the quarter — 0.52% delinquent and non-performing loans to total loans,

NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting

NLS Pharmaceutics Ltd.(NASDAQ: NLSP) (NASDAQ: NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, is pleased to announce the submission of three research abstracts to the2025 Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP). The ASCP Annual Meeting, taking place fromMay

Sabio Launches Creator Television: Transforming Streaming TV with Diverse, Creator-Led Content

Partners with Plex to Globally Distribute Its Creator-Led FAST Channel and Bring Social Video Storytelling to Streaming TV Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF) (the “Company” or “Sabio”), a Los Angeles-based Adtech company specializing in helping top global brands reach, engage, and validate (R.E.V.) streaming TV audiences, today announces the launch of Creator Television (Creator

CONAGRA BRANDS ANNOUNCES DETAILS OF 2025 CAGNY CONFERENCE PRESENTATION WEBCAST

Conagra Brands, Inc. (NYSE: CAG) will present at the 2025 CAGNY (Consumer Analyst Group of New York) Conference on Tuesday, Feb. 18, at 9 a.m. ET. https://mma.prnewswire.com/media/2607314/CB_CMYK_Texture_Logo.jpg Sean Connolly, president and chief executive officer of Conagra Brands, Dave Marberger, executive vice president and chief financial officer, and Bob Nolan, senior vice president of demand science,

Trinity Capital Inc. Provides $25 Million in Growth Capital to Wisetack

Trinity Capital Inc.(NASDAQ: TRIN) (“Trinity Capital”), a leading alternative asset manager, today announced the commitment of $25 million in growth capital to Wisetack, a leading pay-over-time platform for home services. https://mma.prnewswire.com/media/1248863/Trinity_Capital_v1_Logo.jpg Wisetack provides consumer financing for home services such as HVAC, plumbing, and pest control, allowing customers to quickly and easily set up pay-over-time options.

Civista Bancshares, Inc. Announces Fourth-Quarter 2024 Financial Results of $0.63 per Common Share and Full-Year 2024 Financial Results of $2.01 per Common Share

Civista Bancshares, Inc. (NASDAQ:CIVB) (“Civista”) announced its unaudited financial results for the three- and twelve-month periods ending December 31, 2024. https://mma.prnewswire.com/media/241852/civista_bancshares_logo.jpg Fourth quarter and full-year 2024 highlights: — Net income of $9.9 million, or $0.63 per diluted share, for the fourth quarter of 2024, compared to $9.7 million, or $0.62 per diluted share, for the

NANO Nuclear Energy to Work with Thermal Engineering International to Fabricate Primary and Secondary Heat Exchangers for its Portable ODIN Microreactor

(NASDAQ:NNE), New York, N.Y., Jan. 30, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it has contracted with Thermal Engineering International (TEi), a Babcock Power Inc.(R) company, to advance the design

Zevra Therapeutics to Present at the 21st Annual WORLDSymposium(TM)

(NASDAQ:ZVRA), Zevra to receive a 2025 New Treatment Award for MIPLYFFA(TM) at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster presentation, with one poster selected for oral presentation by Dr. Eugen Mengel CELEBRATION, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra,

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program

(NASDAQ:CYTK), Total of $100,000 Awarded to Five Patient Advocacy Organizationsto Support Communications and Community Outreach SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its seventh annual Communications Grant Program, intended to support increased communications, awareness building and community engagement. Five grants in the amount

Scroll to Top